Masafumi Ofuku

Title: Masafumi Ofuku: Innovator in Medicinal Chemistry

Introduction

Masafumi Ofuku is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that address oxidative stress-related diseases. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving health outcomes.

Latest Patents

Masafumi Ofuku holds a patent for a benzotriazole compound aimed at treating and preventing diseases associated with oxidative stress. The invention focuses on inhibiting the protein-protein interaction between Keap1 and Nrf2, thereby activating Nrf2. This compound is represented by a specific formula and includes pharmaceutically acceptable salts. The medicament developed from this compound is intended for the prophylaxis and treatment of various diseases, including chronic kidney disease, non-alcoholic steatohepatitis, and Parkinson's disease, among others. He has 1 patent to his name.

Career Highlights

Throughout his career, Masafumi Ofuku has worked with prominent companies in the pharmaceutical industry. He has been associated with Daiichi Sankyo Company, Limited and Kyoto Pharmaceutical Industries, Ltd. His work in these organizations has allowed him to contribute to significant advancements in medicinal chemistry.

Collaborations

Masafumi Ofuku has collaborated with esteemed colleagues, including Yoshihiro Ogura and Rieko Takano. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.

Conclusion

Masafumi Ofuku's contributions to medicinal chemistry, particularly through his patented benzotriazole compound, highlight his commitment to addressing critical health challenges. His work continues to inspire advancements in the treatment of diseases associated with oxidative stress.